Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

SVB Leerink Downgrades Itamar Medical to Market Perform, Raises Price Target to $31

Author: Benzinga Newsdesk | September 20, 2021 06:35am
SVB Leerink analyst Richard Newitter downgrades Itamar Medical (NASDAQ:ITMR) from Outperform to Market Perform and raises the price target from $30 to $31.

Posted In: ITMR